Comparative study between daily and 5-days-a-week administration of oral 5-fluorouracil chemotherapy in mice: determining the superior regimen

Author： Makino Masato   Shoji Hidehiko   Takemoto Daiki   Honboh Takuya   Nakamura Seiichi   Kurayoshi Kazuo   Kaibara Nobuaki  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.48, Iss.5, 2001-11, pp. : 370-374

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Optimisation of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of hydroxyurea, leucovorin, 5-FU and cisplatin (HLFP regimen) for metastatic oesophageal cancer

By Taeb J.   Artru P.   Baujat B.   Mabro M.   Carola E.   Maindrault F.   Tournigand C.   Krulik M.   Louvet C.   de Gramont A.  

European Journal of Cancer, Vol. 38, Iss. 5, 2002-03 ,pp. : 661-666

Elsevier

Access to resources Recommend Favorite

Treatment of advanced gastric cancer with oral etoposide, leucovorin and tegafur: experience with an oral modification of the etoposide, leucovorin and 5-fluorouracil (ELF) regimen

By Raderer M.   Kornek G.V.   Hejna M.H.L.   Miholic J.   Weinlaender G.   Brodowicz T.   Fiebiger W.C.C.   Valencak J.B.   Scheithauer W.  

European Journal of Cancer, Vol. 34, Iss. 7, 1998-06 ,pp. : 1128-1130

Elsevier

Access to resources Recommend Favorite

Concurrent chemoradiotherapy for esophageal cancer: comparison between intermittent standard-dose cisplatin with 5-fluorouracil and daily low-dose cisplatin with continuous infusion of 5-fluorouracil

By Sai Heitetsu   Mitsumori Michihide   Yamauchi Chikako   Araki Norio   Okumura Setsuko   Nagata Yasushi   Nishimura Yasumasa   Hiraoka Masahiro  

International Journal of Clinical Oncology, Vol. 9, Iss. 3, 2004-06 ,pp. : 149-153

Springer Publishing Company

Access to resources Recommend Favorite

A Phase II Study of Continuous Infusion 5-Fluorouracil (5-FU) with Epirubicin and Cisplatin in Metastatic, Hormone-resistant Prostate Cancer: an Active New Regimen

By Chao D.   von Schlippe M.   Harland S.J.  

European Journal of Cancer, Vol. 33, Iss. 8, 1997-07 ,pp. : 1230-1233

Elsevier

Access to resources Recommend Favorite

Antitumour Activity, Toxicity and Inhibition of Thymidylate Synthase of Prolonged Administration of 5-Fluorouracil in Mice

By Codacci-Pisanelli G.   van der Wilt C.L.   Pinedo H.M.   Franchi F.   Noordhuis P.   Braakhuis B.J.M.   van Laar J.A.M.   Peters G.J.  

European Journal of Cancer, Vol. 31, Iss. 9, 1995-09 ,pp. : 1517-1525

Elsevier

Access to resources Recommend Favorite